Plocabulin, with the CAS number 960210-99-5, is a synthetic compound that belongs to the class of peptides and is primarily investigated for its potential therapeutic applications, particularly in oncology. It functions as a microtubule destabilizer, which interferes with the normal dynamics of microtubules, thereby inhibiting cell division and promoting apoptosis in cancer cells. This mechanism of action positions Plocabulin as a candidate for treating various types of tumors. The compound has been studied in clinical trials, showcasing its efficacy and safety profile in specific cancer types. Its chemical structure includes a sequence of amino acids that contribute to its biological activity. As with many investigational drugs, ongoing research aims to better understand its pharmacokinetics, optimal dosing regimens, and potential side effects. Overall, Plocabulin represents a promising avenue in cancer therapy, reflecting the ongoing efforts to develop targeted treatments that can improve patient outcomes.

Plocabulin

960210-99-5: Plocabulin, with the CAS number 960210-99-5, is a synthetic compound that belongs to the class of peptides and is primarily investigated for its potential therapeutic applications, particularly in oncology. It functions as a microtubule destabilizer, which interferes with the normal dynamics of microtubules, thereby inhibiting cell division and promoting apoptosis in cancer cells. This mechanism of action positions Plocabulin as a candidate for treating various types of tumors. The compound has been studied in clinical trials, showcasing its efficacy and safety profile in specific cancer types. Its chemical structure includes a sequence of amino acids that contribute to its biological activity. As with many investigational drugs, ongoing research aims to better understand its pharmacokinetics, optimal dosing regimens, and potential side effects. Overall, Plocabulin represents a promising avenue in cancer therapy, reflecting the ongoing efforts to develop targeted treatments that can improve patient outcomes.

<p>PM-060184, a tubulin polymerisation inhibitor, is used potentially for the treatment of solid tumours and breast cancer.</p>

CAS 960210-99-5

Plocabulin

PM-060184

Ref: TM-T28428